LTFS
ANIP icon

Ladenburg Thalmann Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$25K Buy
405
+98
+32% +$6.49K ﹤0.01% 3997
2019
Q3 		$22K Sell
307
-219
-42% -$16.4K ﹤0.01% 3974
2019
Q2 		$44K Sell
526
-119
-18% -$8.46K ﹤0.01% 3536
2019
Q1 		$45K Sell
645
-78
-11% -$4.59K ﹤0.01% 3468
2018
Q4 		$34K Buy
723
+282
+64% +$14.8K ﹤0.01% 3518
2018
Q3 		$24K Sell
441
-790
-64% -$48.3K ﹤0.01% 3791
2018
Q2 		$72K Hold
1,231
– – ﹤0.01% 2993
2018
Q1 		$72K Sell
1,231
-3
-0.2% -$190 ﹤0.01% 2993
2017
Q4 		$80K Buy
1,234
+30
+2% +$1.87K ﹤0.01% 2878
2017
Q3 		$63K Sell
1,204
-57
-5% -$2.72K ﹤0.01% 2932
2017
Q2 		$59K Buy
1,261
+98
+8% +$4.73K ﹤0.01% 2907
2017
Q1 		$57K Buy
1,163
+463
+66% +$26K ﹤0.01% 2815
2016
Q4 		$42K Buy
700
+89
+15% +$5.44K ﹤0.01% 2963
2016
Q3 		$41K Buy
611
+309
+102% +$19.3K ﹤0.01% 2926
2016
Q2 		$17K Sell
302
-7
-2% -$340 ﹤0.01% 3435
2016
Q1 		$10K Hold
309
– – ﹤0.01% 3687
2015
Q4 		$14K Buy
309
+187
+153% +$8.05K ﹤0.01% 3458
2015
Q3 		$5K Buy
122
+13
+12% +$740 ﹤0.01% 3907
2015
Q2 		$6K Sell
109
-300
-73% -$17.9K ﹤0.01% 3952
2015
Q1 		$25K Buy
+409
New +$24.9K ﹤0.01% 3039
2014
Q3 		– Sell
-250
Closed -$9K – 3912
2014
Q2 		$9K Sell
250
-150
-38% -$4.7K ﹤0.01% 3117
2014
Q1 		$13K Buy
400
+192
+92% +$5.09K ﹤0.01% 2804
2013
Q4 		$4K Sell
208
-7
-3% -$91 ﹤0.01% 3305
2013
Q3 		$2K Sell
215
-1
-0.5% -$7 ﹤0.01% 3421
2013
Q2 		$1K Buy
+216
New +$1.51K ﹤0.01% 3429

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ANIP Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its ANI Pharmaceuticals (ANIP) stake by 32% in Q4 2019, buying an estimated $6.49K and bringing the position to 405 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3997.

Ladenburg Thalmann Financial Services first reported a position in ANIP in Q2 2013 and has held it in 25 quarters since. The position peaked at $80K in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 405 shares of ANI Pharmaceuticals worth $25K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 98 ANI Pharmaceuticals shares in Q4 2019, an estimated $6.49K.
  • ANI Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3997 holding.
  • Ladenburg Thalmann Financial Services first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
  • Ladenburg Thalmann Financial Services's ANI Pharmaceuticals position peaked at $80K in Q4 2017.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.